HUTCHMED (China) Ltd (HCM) Receivables (2015 - 2026)

HUTCHMED (China) (HCM) has reported Receivables for 12 consecutive years, with $161.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables fell 18.24% year-over-year to $161.6 million in Q2 2026; TTM through Jun 2026 was $161.6 million, a 18.24% decrease from a year earlier, with the FY2025 full-year figure at $178.5 million, changed N/A from the prior year.
• Receivables was $161.6 million for Q2 2026 at HUTCHMED (China), down from $178.5 million in the prior quarter.
• Over five years, Receivables peaked at $197.6 million in Q2 2025 and troughed at $8.3 million in Q4 2023.
• A 5-year average of $121.6 million and a median of $156.4 million in 2023 frame the typical range for Receivables.
• Across the five-year window, Receivables soared 395.16% in 2022 and plunged 31.37% in 2023, its largest moves.
• Over 5 years, Receivables stood at $12.1 million in 2022, then slumped by 31.37% to $8.3 million in 2023, then surged by 2128.75% to $184.7 million in 2024, then declined by 3.31% to $178.5 million in 2025, then declined by 9.5% to $161.6 million in 2026.
• The last three Receivables figures came in at $161.6 million (Q2 2026), $178.5 million (Q4 2025), and $197.6 million (Q2 2025), per Business Quant data.